Zobrazeno 1 - 10 of 228 pro vyhledávání: '"Angela B Smith"'
1
Akademický článek
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
Autor: Angela B Smith, Culley C Carson
Publikováno v: Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 535-545 (2009)
Angela B Smith, Culley C CarsonUniversity of North Carolina Division of Urologic Surgery, Chapel Hill, NC, USAAbstract: Benign prostatic hyperplasia (BPH) is a complex and progressive disease common in aging men. While associated with bothersome lowe
Externí odkaz: https://doaj.org/article/c702bb03c5694e1b8c42a294f892da81
Zobrazit plný text záznamu
2
Akademický článek
Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer
Autor: John L. Gore, Erika M. Wolff, Bryan A. Comstock, Kristin M. Follmer, Michael G. Nash, Anirban Basu, Stephanie Chisolm, Douglas B. MacLean, Jenney R. Lee, Yair Lotan, Sima P. Porten, Gary D. Steinberg, Sam S. Chang, Scott M. Gilbert, Larry G. Kessler, Angela B. Smith, CISTO Collaborative
Publikováno v: BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Bladder cancer poses a significant public health burden, with high recurrence and progression rates in patients with non-muscle-invasive bladder cancer (NMIBC). Current treatment options include bladder-sparing therapies (BST) and
Externí odkaz: https://doaj.org/article/3af6c3a91f5d4425a09260ced928bdc7
Zobrazit plný text záznamu
4
Minimal Patient-Reported Side Effects for a Chemoablative Gel (UGN-102) Used as Frontline Treatment in Adults with Nonmuscle-Invasive Bladder Cancer
Autor: Angela M. Stover, Ramsankar Basak, Dana Mueller, Robert Lipman, Randall Teal, Alison Hilton, Kara Giannone, Myra Waheed, Angela B. Smith
Publikováno v: Journal of Urology. 208:580-588
Optima II ("OPTimized Instillation of Mitomycin for Bladder Cancer Treatment," clinicaltrials.gov: NCT03558503) was a phase 2b trial evaluating a nonsurgical alternative as a primary treatment for nonmuscle-invasive bladder cancer (NMIBC). Patients r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1007b454cf76d5e83b4c11c67fdc342
https://doi.org/10.1097/ju.0000000000002747
Zobrazit plný text záznamu
5
Akademický článek
Different models for prediction of radical cystectomy postoperative complications and care pathways
Autor: Jacob Taylor, Xiaosong Meng, Audrey Renson, Angela B. Smith, James S. Wysock, Samir S. Taneja, William C. Huang, Marc A. Bjurlin
Publikováno v: Therapeutic Advances in Urology, Vol 11 (2019)
Background: Radical cystectomy for bladder cancer has one of the highest rates of morbidity among urologic surgery, but the ability to predict postoperative complications remains poor. Our study objective was to create machine learning models to pred
Externí odkaz: https://doaj.org/article/116779c9051e4dd68722255940299e80
Zobrazit plný text záznamu
6
Linguistic Differences in Personal Statements of Urology Residency Applicants by Self-Reported Race and Ethnicity
Autor: Davis P. Viprakasit, Katy Reines, Alysen Demzik, Stephanie Brown, Hung-Jui Tan, Eric Wallen, Pauline Filippou, Angela B. Smith, Christopher Chew
Publikováno v: Urology. 162:137-143
To assess a potential source of bias that could contribute to underrepresentation of minorities in urology, we analyzed differences in linguistic characteristics in personal statements between urology residency applicants of various racial and ethnic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::962721a0618457f011a8c08419cac122
https://doi.org/10.1016/j.urology.2021.05.047
Zobrazit plný text záznamu
7
Quality of Life and Health State Utilities in Bladder Cancer
Autor: Angela B. Smith, Sean McCabe, Allison M. Deal, Amy Guo, Kathryn H. Gessner, Robert Lipman, Stephanie Chisolm, Lauren Ahlschlager, John L. Gore
Publikováno v: Bladder Cancer. 8:55-70
BACKGROUND: Bladder cancer treatments may variably impact health-related quality of life (QOL). OBJECTIVE: To characterize the quality of life of patients with bladder cancer at various time points across the continuum of bladder cancer care from non
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::298488879f39e9d608ee32e23f0067ce
https://doi.org/10.3233/blc-211615
Zobrazit plný text záznamu
10
Reduced Dose Intravesical Bacillus Calmette-Guerin: Why It Might Not Matter
Autor: Ashish M. Kamat, Niyati Lobo, Seth P. Lerner, Roger Li, Justin T. Matulay, Joan Palou, J. Alfred Witjes, Morgan Rouprêt, Angela B. Smith, Sam S. Chang, Neal D. Shore, Gary D. Steinberg, Colin P. Dinney, Robert S. Svatek, Donald L. Lamm
Publikováno v: Bladder Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Bladder Cancer, 8, 113-117
Bladder Cancer, 8, 2, pp. 113-117
When it comes to the treatment of patients with non-muscle-invasive bladder cancer (NMIBC) with intravesical bacillus Calmette-Guérin (BCG), two questions must be considered: 1) what dose to give, and 2) for how long? The issue of optimal dose and d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc0d53f780f1012774120cf3d4046e1
https://doi.org/10.3233/blc-211648
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje